For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 0 | 0 | 0 | 0* |
| Research and development | 7,000 | 10,500 | 10,500 | -112,228* |
| General and administrative | 108,469 | 126,964 | 144,434 | 237,795* |
| Total operating expenses | 115,469 | 137,464 | 154,934 | 125,567* |
| Interest expense, officer loan | 0 | - | - | - |
| Interest expense | - | 12,023 | 12,047 | 10,415.5* |
| Interest expense, convertible debt | 11,762 | - | - | - |
| Net loss | -127,231 | -149,487 | -166,981 | -135,982.5 |
| Diluted EPS | -0.01 | - | - | - |
| Diluted Average Shares | 22,404,885 | - | - | - |
Nexscient, Inc. (NXNT)
Nexscient, Inc. (NXNT)